CD70/CD27 ligand, a member of the TNF family, is expressed in human brain tumors
Open Access
- 4 January 2002
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 98 (3) , 352-356
- https://doi.org/10.1002/ijc.10207
Abstract
CD70 (CD27 ligand) has been implicated in proapoptotic signals mediated by its receptor CD27 in lymphocytes as well as in proliferative effects induced by reverse signaling in CD70‐positive hematopoetic tumor cells. We were able to show that CD70 is expressed at the mRNA and protein level in human meningioma cells, glioma cells from solid human gliomas as well as glioma cell lines and 1 ependynoma. The intensity of CD70 expression varies considerably between different samples from 1 tumor type. In the U343 glioma cell line, CD70 was preferentially localized in the cell processes. Thus, our studies identify CD70 as a new marker molecule in brain tumors that are of nonhematopoetic origin.Keywords
This publication has 30 references indexed in Scilit:
- Aberrant expression and reverse signalling of CD70 on malignant B cellsBritish Journal of Haematology, 1999
- Anti-Tumor Immunity Elicited by a Recombinant Vaccinia Virus Expressing CD70 (CD27L)Human Gene Therapy, 1999
- CD27/CD70 interaction directly induces natural killer cell killing activityImmunology, 1996
- Expression of Somatostatin Receptor Subtypes in Cultured Astrocytes and GliomasJournal of Neurochemistry, 1995
- Comparative molecular modelling of the Fas-ligand and other members of the TNF familyMolecular Immunology, 1995
- CD27: marker and mediator of T-cell activation?Immunology Today, 1994
- The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and deathCell, 1994
- A family of ligands for the TNF receptor superfamilyThe International Journal of Cell Cloning, 1994
- Fas transduces activation signals in normal human T lymphocytes.The Journal of Experimental Medicine, 1993
- A novel domain within the 55 kd TNF receptor signals cell deathCell, 1993